Saplot, Ruben L.

HRN: 21-74-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
CEFTRIAXONE 1G (VIAL)
08/02/2022
08/09/2022
IV
2g
Q24h
Appendicitis
Waiting Final Action 
08/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2022
08/09/2022
IV
500mg
Q8h
Appendicitis
Waiting Final Action 
08/04/2022
CEFTRIAXONE 1G (VIAL)
08/04/2022
08/11/2022
IVT
2g
Q12
Psoas Abscess
Waiting Final Action 
08/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2022
08/16/2022
IVT
500mg
Q6
Ruptured Appendicitis With Generalized Peritonitis
Waiting Final Action 
08/07/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/07/2022
08/17/2022
IVT
4.5g
Q6
Ruptured Appendicitis With Generalized Peritonitis
Waiting Final Action 
08/09/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/09/2022
08/16/2022
TOPICAL
2%
Bid
Blisters
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: